File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.2147/IDR.S451742
- Scopus: eid_2-s2.0-85191296186
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: The Emergence of Candida auris is Not Associated with Changes in Antifungal Prescription at Hospitals
Title | The Emergence of Candida auris is Not Associated with Changes in Antifungal Prescription at Hospitals |
---|---|
Authors | |
Keywords | antifungal prescription epidemiology infection control measure outbreak |
Issue Date | 11-Apr-2024 |
Publisher | Taylor and Francis Group |
Citation | Infection and Drug Resistance, 2024, v. 17, p. 1419-1429 How to Cite? |
Abstract | Purpose: This study describes the emergence of Candida auris in Hong Kong, focusing on the incidence and trends of different Candida species over time. Additionally, the study analyzes the relationship between C. auris and antifungal prescription, as well as the impact of outbreaks caused by C. auris. Patients and Methods: Data were collected from 43 public hospitals across seven healthcare networks (A to G) in Hong Kong, including Candida species culture and antifungal prescription information. Among 150,267 patients with 206,405 hospitalization episodes, 371,653 specimens tested positive for Candida species. Trends in Candida species and antifungal prescription were analyzed before (period 1: 2015 1Q to 2019 1Q) and after (period 2: 2019 2Q to 2023 2Q) the emergence of C. auris in Hong Kong. Results: Candida albicans was the most prevalent species, accounting for 57.1% (212,163/371,653) of isolations, followed by Candida glabrata (13.1%, 48,666), Candida tropicalis (9.2%, 34,261), and Candida parapsilosis (5.3%, 19,688). C. auris represented 2.0% of all Candida species isolations. Comparing period 2 to period 1, the trend of C. albicans remained stable, while C. glabrata, C. tropicalis, and C. parapsilosis demonstrated a slower increasing trend in period 2 than in period 1. Other species, including C. auris, exhibited a 1.1% faster increase in trend during period 2 compared to period 1. Network A, with the highest antifungal prescription, did not experience any outbreaks, while networks F and G had 40 hospital outbreaks due to C. auris in period 2. Throughout the study period, healthcare networks B to G had significantly lower antifungal prescription compared to network A, ranging from 54% to 78% less than that of network A. Conclusion: There is no evidence showing correlation between the emergence of C. auris and antifungal prescription in Hong Kong. Proactive infection control measures should be implemented to prevent nosocomial transmission and outbreak of C. auris. |
Persistent Identifier | http://hdl.handle.net/10722/350879 |
ISSN | 2023 Impact Factor: 2.9 2023 SCImago Journal Rankings: 0.743 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wong, Shuk Ching | - |
dc.contributor.author | Chau, Pui Hing | - |
dc.contributor.author | Chen, Hong | - |
dc.contributor.author | So, Simon Yung Chun | - |
dc.contributor.author | Chiu, Kelvin Hei Yeung | - |
dc.contributor.author | Chen, Jonathan Hon Kwan | - |
dc.contributor.author | Li, Xin | - |
dc.contributor.author | Chui, Celine Sze Ling | - |
dc.contributor.author | Yuen, Kwok Yung | - |
dc.contributor.author | Cheng, Vincent Chi Chung | - |
dc.date.accessioned | 2024-11-06T00:30:23Z | - |
dc.date.available | 2024-11-06T00:30:23Z | - |
dc.date.issued | 2024-04-11 | - |
dc.identifier.citation | Infection and Drug Resistance, 2024, v. 17, p. 1419-1429 | - |
dc.identifier.issn | 1178-6973 | - |
dc.identifier.uri | http://hdl.handle.net/10722/350879 | - |
dc.description.abstract | <p>Purpose: This study describes the emergence of Candida auris in Hong Kong, focusing on the incidence and trends of different Candida species over time. Additionally, the study analyzes the relationship between C. auris and antifungal prescription, as well as the impact of outbreaks caused by C. auris. Patients and Methods: Data were collected from 43 public hospitals across seven healthcare networks (A to G) in Hong Kong, including Candida species culture and antifungal prescription information. Among 150,267 patients with 206,405 hospitalization episodes, 371,653 specimens tested positive for Candida species. Trends in Candida species and antifungal prescription were analyzed before (period 1: 2015 1Q to 2019 1Q) and after (period 2: 2019 2Q to 2023 2Q) the emergence of C. auris in Hong Kong. Results: Candida albicans was the most prevalent species, accounting for 57.1% (212,163/371,653) of isolations, followed by Candida glabrata (13.1%, 48,666), Candida tropicalis (9.2%, 34,261), and Candida parapsilosis (5.3%, 19,688). C. auris represented 2.0% of all Candida species isolations. Comparing period 2 to period 1, the trend of C. albicans remained stable, while C. glabrata, C. tropicalis, and C. parapsilosis demonstrated a slower increasing trend in period 2 than in period 1. Other species, including C. auris, exhibited a 1.1% faster increase in trend during period 2 compared to period 1. Network A, with the highest antifungal prescription, did not experience any outbreaks, while networks F and G had 40 hospital outbreaks due to C. auris in period 2. Throughout the study period, healthcare networks B to G had significantly lower antifungal prescription compared to network A, ranging from 54% to 78% less than that of network A. Conclusion: There is no evidence showing correlation between the emergence of C. auris and antifungal prescription in Hong Kong. Proactive infection control measures should be implemented to prevent nosocomial transmission and outbreak of C. auris.</p> | - |
dc.language | eng | - |
dc.publisher | Taylor and Francis Group | - |
dc.relation.ispartof | Infection and Drug Resistance | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | antifungal prescription | - |
dc.subject | epidemiology | - |
dc.subject | infection control measure | - |
dc.subject | outbreak | - |
dc.title | The Emergence of Candida auris is Not Associated with Changes in Antifungal Prescription at Hospitals | - |
dc.type | Article | - |
dc.identifier.doi | 10.2147/IDR.S451742 | - |
dc.identifier.scopus | eid_2-s2.0-85191296186 | - |
dc.identifier.volume | 17 | - |
dc.identifier.spage | 1419 | - |
dc.identifier.epage | 1429 | - |
dc.identifier.eissn | 1178-6973 | - |
dc.identifier.issnl | 1178-6973 | - |